Literature DB >> 32869702

Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patients.

Alexandre Candellier1,2, Anaïs Scohy3, Nicolas Gillet4, Benoit Muylkens4, Johann Morelle1, Leïla Belkhir5, Damien Coupeau4, Michel Jadoul1, Éric Goffin1.   

Abstract

The pandemic of respiratory disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is life-threatening in peritoneal dialysis (PD) patients. In PD patients with systemic viral infections, peritoneal effluent may be theoretically contaminated. We searched for the presence of SARS-CoV-2 genetic material by real-time reverse transcriptase-polymerase chain reaction assays in serial PD effluents of three PD infected patients. Nasopharyngeal swabs obtained at admission showed high viral load in all three patients, whereas none of the PD effluent specimen tested positive, even after dialysate concentration. Those results support at most a very low SARS-CoV-2 dissemination risk by the peritoneal effluent of PD patients. Imposing special disposal procedures, such as the instillation of hypochlorite in the drainage bags to prevent viral spread to health-care workers, are probably not required.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; peritoneal dialysis; peritoneal effluent

Mesh:

Substances:

Year:  2020        PMID: 32869702     DOI: 10.1177/0896860820953061

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  SARS-CoV-2 in Spent Dialysate from Chronic Peritoneal Dialysis Patients with COVID-19.

Authors:  Xiaoling Wang; Amrish Patel; Lela Tisdale; Zahin Haq; Xiaoling Ye; Rachel Lasky; Priscila Preciado; Xia Tao; Gabriela Ferreira Dias; Joshua E Chao; Mohamad Hakim; Maggie Han; Ohnmar Thwin; Jochen Raimann; Dinesh Chatoth; Peter Kotanko; Nadja Grobe
Journal:  Kidney360       Date:  2020-12-01

2.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in peritoneal fluid of coronavirus disease 2019 (COVID-19) patients-Prevalence and significance.

Authors:  Barbara Seeliger; Patrick Pessaux
Journal:  Surgery       Date:  2021-02-16       Impact factor: 3.982

3.  Swab test in biological fluids as predictor of COVID-19 transmission risk during surgery: a prospective cross-sectional study from an Italian COVID center.

Authors:  N Fabbri; A Pesce; A Ussia; F D'Urbano; S Pizzicotti; S Greco; C V Feo
Journal:  BMC Surg       Date:  2022-03-30       Impact factor: 2.102

4.  Laparoscopic surgery during the COVID-19 pandemic: detection of SARS-COV-2 in abdominal tissues, fluids, and surgical smoke.

Authors:  Isaac Cheruiyot; Prabjot Sehmi; Brian Ngure; Musa Misiani; Paul Karau; Beda Olabu; Brandon Michael Henry; Giuseppe Lippi; Roberto Cirocchi; Julius Ogeng'o
Journal:  Langenbecks Arch Surg       Date:  2021-03-06       Impact factor: 3.445

5.  Absence of SARS-CoV-2 RNA in Peritoneal Fluid During Surgery in Pregnant Women Who Are COVID-19 Positive.

Authors:  Artur J Jakimiuk; Marcin Januszewski; Malgorzata Santor-Zaczynska; Alicja A Jakimiuk; Tomasz Oleksik; Marek Pokulniewicz; Waldemar Wierzba
Journal:  J Minim Invasive Gynecol       Date:  2021-06-15       Impact factor: 4.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.